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1  | INTRODUC TION
The pubertal transition represents a period of dramatic alterations 
in body composition and sex hormone profiles. Previous reports 
in girls1-4 suggest that obesity is associated with earlier onset of 
puberty and hyperandrogenemia, whereas the opposite may be true 
in boys.5,6 As most of these reports were cross-sectional, it is unclear 
whether the speed of fat accumulation or baseline body fat influ-
enced the onset of puberty, and to what extent sex steroid hormones 
as opposed to other markers of puberty were altered. How growth 
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Abstract
Objective: It is unclear how childhood adipose tissue deposition influences sex hor-
mone profiles in later adolescence.
Design: Prospective cohort study.
Participants: Children (n = 418) with a mean age of 10.5 (1.5) years at visit 1 and 16.7 
(1.2) at visit 2 in the Exploring Perinatal Outcomes among Children (EPOCH) Study.
Measurements: We used reverse-scale Cox proportional hazard models to assess 
associations between pubertal dehydroepiandrosterone (DHEA), testosterone (T), 
and oestradiol (E2) and childhood-to-puberty rate of change in visceral (VAT) and 
subcutaneous adipose tissue (SAT). Models stratified by sex and adjusted for child-
hood adiposity, maternal factors, birthweight and pubertal onset, and then further 
adjusted for insulin, luteinizing hormone (LH), leptin and hepatic fat fraction.
Results: Among boys, more rapid accumulation of either VAT or SAT was associated 
with lower testosterone at visit 2 (HR 0.86, and .96, respectively, both P < .0001), in-
dependently of race/ethnicity, LH, leptin and hepatic fat fraction. Among boys, more 
childhood VAT was associated with lower testosterone in adolescence (HR 0.98, 
P = .003), but this association did not persist after adjustment for leptin or insulin. 
No associations were observed between either fat measure and oestradiol or DHEA 
in boys. In girls, no associations between childhood fat or fat accumulation and sex 
hormones were observed.
Conclusions: More rapid accumulation of fat is associated with lower testosterone 
in boys. These associations suggest that fat growth influences androgen profiles in 
adolescent boys. Since fat accumulation is a modifiable risk factor, the study results 
provide a possible intervention target and time period for improving adult health.
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in specific adipose tissue depots, particularly visceral adipose tissue 
(VAT) and subcutaneous adipose tissue (SAT), are associated with 
sex profiles in adolescence is also not established. Finally, adipose 
tissue production of leptin may stimulate gonadotropin secretion 
and luteinizing hormone (LH) release as well as insulin resistance, 
but whether the associations between fat accumulation and sex hor-
mones occur after accounting for luteinizing hormone (LH), fasting 
insulin, hepatic fat deposition and leptin has not been studied.
The Exploring Perinatal Outcomes in Children (EPOCH) study 
is a longitudinal cohort study of youth in Colorado.7 Approximately 
418 children had magnetic resonance imaging (MRI) assessed VAT 
and SAT during prepuberty and early puberty, followed by repeated 
adiposity and sex hormone measures six years later. In this report, 
we examined the associations between baseline VAT and SAT in 
childhood, and growth rate in VAT and SAT with sex hormone levels 
later in adolescence. We also examined whether these associations 
changed after adjusting for potential mediators including LH, fast-
ing insulin, hepatic fat and fasting leptin concentrations. Based on 
previous studies in children, we hypothesized that greater VAT and 
VAT growth would be associated with higher testosterone levels in 
girls at the follow-up visit,1-4 whereas greater VAT and VAT growth 
would be associated with lower testosterone levels in boys.5,6 Based 
on studies in adult women,8 we also hypothesized that greater SAT 
would be associated with higher oestradiol levels in girls at the 
 follow-up visit.
2  | MATERIAL S AND METHODS
2.1 | Participants
The design, methods and baseline characteristics of EPOCH partici-
pants have been previously described.7 EPOCH is an observational 
prospective study that recruited healthy 6- to 13-year-old children 
who were offspring of singleton pregnancies, born at a single hos-
pital in Denver between 1992 and 2002, whose biological mothers 
were members of Kaiser Permanente of Colorado (KPCO). The study 
population was sampled to reflect similar racial and ethnic distribu-
tions of Colorado. The EPOCH study included an oversampling of 
offspring of mothers who had experienced gestational diabetes in 
pregnancy, and average BMI in EPOCH is slightly higher than the 
national standard.9 Children and their mothers were invited to par-
ticipate in two research visits at average ages of 10.5 (SD = 1.5) and 
16.7 (SD = 1.2). While a total of 604 children attended the 1st re-
search visit, this analysis focused on the 418 children who attended 
both visits. All participants provided informed consent, and youths 
provided written assent. The study was approved by the Colorado 
Multiple Institutional Review Board.
2.2 | Measures of adiposity
Childhood height and weight were measured in light clothing and 
without shoes. Weight was measured to the nearest 0.1 kg using an 
electronic scale. Height was measured to the nearest 0.1 cm using a 
portable stadiometer. BMI was calculated as kg/m2. Waist circumfer-
ence was measured according to the National Health and Nutrition 
Examination Survey protocol as previously described.10 At both visits, 
MRI of the abdominal region was used to quantify visceral adipose 
tissue (VAT) and subcutaneous adipose tissue (SAT) with a 3 T HDx 
Imager (General Electric) by a trained technician. Each study partici-
pant was placed supine and a series of T1-weighted coronal images 
were taken to locate the L4/L5 plane. One axial, 10 mm, T1-weighted 
image, at the umbilicus or L4/L5 vertebrae, was analysed to deter-
mine SAT and VAT content. Images were analysed by a single reader, 
blinded to exposure status. With measures of VAT and SAT, we gener-
ated VAT/SAT ratios. Previous reports in the EPOCH cohort have ex-
amined the correlation between BMI and specific markers of visceral 
adiposity. BMI has high correlation with SAT in boys (Pearson's r = .94) 
and girls (r = .91), but the correlation with VAT is moderate (r = .65 in 
boys, r = .68 in girls); correlation between visceral fat mass and waist 
circumference was similar.10 Hepatic imaging was performed at the 
2nd research visit using a magnitude based, 6-echo, spoiled gradi-
ent-recalled echo sequence. Hepatic fat fraction (HFF) was calculated 
from the mean pixel signal intensity data, for each echo acquisition 
using an open source Osirix algorithm. This fraction was then multi-
plied by 100 such that a value of 1 is equivalent to 1% HFF.
2.3 | Dehydroepiandrosterone, testosterone, 
oestradiol measurements
A fasting blood draw after an overnight fast occurred for all consent-
ing children at the second visit. Sera were refrigerated and analysed 
within 24 hours of collection. All laboratory measurements were per-
formed at the Colorado Clinical Translational Science Institute Core 
Laboratories. Serum oestradiol was measured by using a Beckman 
Coulter chemiluminescent with a limit of detection of 10.0 pg/mL. 
Serum total testosterone was measured by using a Beckman Coulter 
1-step competitive with a limit of detection of 17 ng/dL. Serum 
DHEA was measured by using a Beckman Coulter chemiluminescent 
with a limit of detection of 2 µg/dL.
2.4 | Covariate measurements
The KPCO Perinatal database, an electronic database linking the ne-
onatal and perinatal medical record, was used to collect birthweight. 
Race/ethnicity was self-reported using 2000 US Census-based ques-
tions and categorized as Hispanic (any race), non-Hispanic white, 
non-Hispanic African American and non-Hispanic other. Pubertal 
development was self-assessed using a diagrammatic representa-
tion of Tanner staging adapted from Marshall and Tanner; sexual 
maturation self-assessment was recently shown to be in excellent 
agreement with physician-assessed Tanner stage,11 although lack 
of direct testicular measurement could potentially over-estimate 
pubertal stage. For the purpose of the analysis, youth were catego-
rized as prepubertal (Tanner <2) and pubertal (Tanner 2-5), and as 
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white or nonwhite. Maternal level of education (high school or less 
vs more than high school) and total household income (<$50 000 vs 
more than $50 000) were self-reported at the study visit. Fasting 
insulin was measured by a radioimmunoassay method. Plasma leptin 
concentration was measured by using a Millipore radioimmunoassay 
with a sensitivity of 0.5 ng/mL. Serum LH was determined by using 
a Beckman Coulter chemiluminescent assay with a sensitivity of 
0.12 mIU/mL.
2.5 | Statistical analysis
Girls and boys were examined separately. Baseline characteristics 
were described using sample size and percentages for categorical 
variables and means and standard deviations for numeric variables 
(Table 1). When considering sex steroid profiles, given the young age 
of study participants, we needed to consider the substantial number 
of values that fell below the level of detection.9-12 Many authors 
choose to replace values below the limit of detection with randomly 
sampled values, or with a value halfway between zero and the de-
tection limit. These approaches have been critiqued for introducing 
bias or reducing statistical power.12-15 We chose instead to employ 
the reverse-scale Cox proportional hazards approach,16 an unbiased 
approach which maintains power by including both values above and 
below the limit of detection. The approach does not rely on either 
estimation or imputation.16
In classical survival analysis, the data are right-censored. By con-
trast, sex hormone data are left-censored at the level of detection. 
It is important to realize that data below the level of detection still 
conveys information. Intuitively, if a person has a sex hormone level 
below the limit of detection, the level must be very low. This leaves 
the analyst with a thorny problem. How do we apply methods for 
right-censored data to left-censored data?
 
Boys (N = 209) Girls (N = 209)
Visit 1 Visit 2 Visit 1 Visit 2
Age (y) 10.5 (1.5) 16.6 (1.2) 10.4 (1.5) 16.7 (1.2)
Stage of puberty (n, %)
Tanner 1 113 (54%) 0 74 (35%) 0
Tanner 2 65 (31%) 3 (1%) 77 (37%) 0
Tanner 3 24 (12%) 5 (2%) 38 (18%) 16 (8%)
Tanner 4 6 (3%) 73 (35%) 19 (9%) 93 (45%)
Tanner 5 0 126 (61%) 1 (0.5%) 100 (48%)
Race/ethnicity (n, %)
Non-Hispanic White 101 (48%)  112 (54%)  
Hispanic 81 (39%)  68 (33%)  
African American 15 (7%)  18 (9%)  
Other 12 (6%)  11 (5%)  
Birthweight (lbs) 7.9 (4.7)  7.6 (4.5)  
Maternal education, high school or 
less (n, %)
35 (17%)  39 (19%)  
Maternal income < $50 000 (n, %) 98 (47%)  89 (43%)  
Body mass index (kg/m2) 19.1 (4.7) 23.7 (5.5) 18.5 (4.2) 23.6 (5.7)
Fasting insulin (IU/L)  16.3 (11.3)  17.5 (11.4)
Luteinizing hormone (IU/L)  4.2 (3.9)  10.7 (31.3)
Leptin (ng/mL)  6.6 (8.2)  19.6 (15.4)
Hepatic fat fraction (%)  2.7 (3.7)  2.2 (2.2)
Visceral adiposity (VAT) (cm2) 22 (15) 32 (22) 22 (15) 34 (22)
Subcutaneous adiposity (SAT) (cm2) 116 (113) 172 (154) 119 (98) 232 (144)
VAT/SAT 0.26 (0.14) 0.24 (0.13) 0.22 (0.10) 0.16 (0.06)
Oestradiol (pg/mL)  27.0 (12.5)  86.3 
(86.6)
Testosterone (ng/dL)  489.5 
(146.8)
 41.1 (16.0)




TA B L E  1   Participant characteristics in 
EPOCH. Means (standard deviations [SD]) 
or n (per cent) shown
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To apply classical survival methods to sex hormone data, the 
scale of the data must be reversed, through a transformation. The 
scale of each sex hormone is reversed by subtracting observed sex 
hormone levels from the maximum observed value for that sex hor-
mone in the data set. This effectively converts left-censored to right-
censored data. The resulting model predicts the risk of sex steroid 
levels above the limit of detection. Thus, a hazard ratio less than 1 
indicates a greater risk of having undetectable sex steroid levels. The 
approach allows the analyst to describe the percentage of the pop-
ulation below any sex steroid hormone level of interest, as shown in 
Figure 1.
We fit nine separate reverse-scale Cox proportional hazard mod-
els. Each model had a different hormone outcome (DHEA, testoster-
one or oestradiol) and a different measure of adiposity as a predictor 
(VAT, SAT, or VAT/SAT). For the best fitting models, we assessed the 
validity of the proportional hazard assumption, and reported model 
generated hazard ratios, parameter estimates, 95% confidence inter-
vals and graphics.
The base model included the specific fat measure at visit 1, 
growth rate in adiposity between the two visits, and the follow-
ing covariates: maternal education and income, birthweight and 
pubertal stage at visit 1. Growth rate in adiposity was computed 
as the difference between the adiposity measure at visit 2 and 
the measure at visit 1, divided by the difference in age between 
visit 2 and age at visit 1. Subsequent models further adjusted 
for visit 2 LH, fasting insulin, leptin and hepatic fat to determine 
whether addition of these potential mediators changed the asso-
ciation. We also evaluated interactions between race/ethnicity 
with the initial fat measure and growth rate in that specific fat 
measure; if no interactions were detected, models were adjusted 
only for the main effect of race/ethnicity. Analyses were per-
formed using the Statistical Analysis Software (SAS) version 9.4 
(SAS Institute), and all tests were two-sided with statistical sig-
nificance set at P < .05.
3  | RESULTS
Table 1 shows participant characteristics by sex. At the first visit, 
both boys and girls were between 6 and 14 years old (on average 
10.5 ± 1.5 years), and at the second visit, both boys and girls were be-
tween 12 and 20 years old (on average 16.7 ± 1.2 years). At the first 
visit, approximately half of the boys were prepubertal compared to 
about 1/3 of the girls; by visit 2, all of the children had reached the onset 
of puberty. One boy was Tanner stage 2 at <11.5 years of age and one 
girl was Tanner stage 2 at <10.5 years of age, and conversely, no girls 
were Tanner stage 1 at 12 years of age and no boys were Tanner stage 
1 at 14 years of age. About half were non-Hispanic white. Although 
most mothers had more than a high school education, almost half of the 
population had an annual income less than $50 000 per year. Table 1 
also shows average adipose tissue areas and sex steroid levels. While 
DHEA concentrations were consistently above the level of detection, a 
substantial proportion of children had oestradiol and testosterone con-
centrations below the limit of detection. At visit 2, approximately 12% 
of girls and 1% of boys had undetectable testosterone levels, and 7% of 
girls and 6% of boys had undetectable oestradiol levels.
Among boys, Table 2 shows the association between change in 
adipose tissue depots between visit 1 and visit 2, as well as baseline 
adipose tissue, with the risk of undetectable hormones at visit 2. 
Even after adjustment for baseline VAT and SAT, more rapid growth 
in VAT and more rapid growth in SAT were both associated with 
higher risk of undetectable testosterone at follow-up (due to re-
verse-scale Cox proportional hazards modelling, an HR <1 indicates 
greater risk). For every 1 mm2 increase in VAT, there was a 14% in-
crease in the risk of testosterone values below the limit of detection 
(HR: 0.86, P < .0001). For every 1 mm2 increase in SAT, there was 
a 4% increase in the risk of testosterone values below the limit of 
detection (HR: 0.96, P < .0001).
Figure 1 shows the estimated proportions of the adolescent 
male population below a specific testosterone level. Different lines 
F I G U R E  1   Proportion of adolescent 
boys with testosterone levels below the 
level of detection at their follow-up visit, 
by percentiles of the VAT growth rate
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show the different curves by percentile of VAT growth rate. The 
curve for the 10th percentile in VAT growth rate lies at the bottom, 
and the curve for the 90th percentile lies at the top. The estimates 
are drawn from reverse Cox proportional hazard models. The VAT 
growth rate is treated as a continuous predictor, so as the rate of 
growth in VAT increases, the proportion of the population below a 
specific testosterone value increases. Estimates can be obtained 
for any percentile desired: only the 10th, 50th and 90th are shown 
here for clarity.
Higher levels of VAT at baseline were also associated with a 2% 
increase in the risk of undetectable testosterone at visit 2 (HR: 0.98, 
P < .003). However, higher concentrations of VAT/SAT at baseline 
were associated with a lower risk of undetectable testosterone at 
future visits (HR: 4.04, P = .028), suggesting that boys with rela-
tive large amounts of visceral fat relative to subcutaneous fat prior 
to the pubertal transition were more likely to have detectable tes-
tosterone levels at follow-up. These patterns did not change with 
adjustment for race/ethnicity (results not shown). Among girls, no 
fat depots or change in fat depots were associated with future sex 
steroid levels (Table 2).
Among boys, the associations between growth rate of VAT and 
growth rate of SAT with testosterone persisted after adjustment for 
other variables, including insulin, LH, leptin and hepatic fat (Table 3), 
suggesting that these factors did not account for the association be-
tween growth of fat with future low testosterone. The association 
between baseline VAT with future testosterone was attenuated in 
models including fasting insulin and models including leptin, suggest-
ing that these variables either confounded or mediated the relation-
ship between baseline VAT and future testosterone. Similarly, the 
association between baseline VAT/SAT with future testosterone was 
also attenuated by fasting insulin and leptin, suggesting that these 
variables either confounded or mediated the relationship between 
baseline VAT/SAT and future testosterone. These associations also 
persisted after adjustment for race/ethnicity (results not shown).
4  | DISCUSSION
In a cohort of children who had not yet completed their puber-
tal transition, we found that, among boys, more rapid growth in 
 
Testosterone Oestradiol DHEA
HR (95% CI) HR (95% CI) HR (95% CI)
Boys—VAT models
Adjusted for birthweight, maternal education, income, visit 1 pubertal stage
VAT at visit 1 0.98 (0.003) 1.00 (0.60) 1.00 (0.99)
Change in VAT 0.86 (<0.0001) 0.99 (0.61) 0.97 (0.30)
Boys—SAT models
Adjusted for birthweight, maternal education, income, visit 1 pubertal stage
SAT at visit 1 1.00 (0.07) 1.00 (0.40) 1.00 (0.57)
Change in SAT 0.96 (<0.0001) 1.00 (0.28) 0.99 (0.17)
Boys—VAT/SAT models
Adjusted for birthweight, maternal education, income, visit 1 pubertal stage
VAT/SAT at visit 1 4.04 (0.028) 0.55 (0.36) 1.03 (0.97)
Change in VAT/SAT 0.61 (0.32) 0.11 (0.61) 0.11 (0.59)
Girls—VAT models
Adjusted for birthweight, maternal education, income, visit 1 pubertal stage
VAT at visit 1 0.99 (0.13) 1.00 (0.93) 1.00 (0.63)
Change in VAT 1.01 (0.82) 1.00 (0.95) 1.00 (0.95)
Girls—SAT models
Adjusted for birthweight, maternal education, income, visit 1 pubertal stage
SAT at visit 1 1.00 (0.76) 1.00 (0.50) 1.00 (0.26)
Change in SAT 1.00 (0.93) 1.00 (0.72) 1.00 (0.55)
Girls—VAT/SAT models
Adjusted for birthweight, maternal education, income, visit 1 pubertal stage
VAT/SAT at visit 1 0.20 (0.24) 0.61 (0.69) 2.10 (0.56)
Change in VAT/SAT 0.02 (0.70) 4.01 (0.88) 5420 (0.39)
The bold values are values that are significant at P < 0.05.
TA B L E  2   Association between change 
in adiposity between visit 1 and visit 2 
(predictor) with circulating sex steroid 
hormones at visit 2 (outcome). Hazard 
ratios and 95% confidence intervals 
shown (HR, 95% CI); hazard ratios < 1 
indicate greater risk for undetectable sex 
steroid concentrations at visit 2
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fat depots predicted greater risk for low testosterone concentra-
tions roughly 6 years later. These associations were independ-
ent of other factors known to affect testosterone production, 
including LH, insulin, leptin and hepatic fat. These associations 
were also independent of baseline quantities of fat. These find-
ings suggest that the speed of fat accumulation, a modifiable ex-
posure, is an important determinant of future androgen profiles 
in boys. We did not observe relationships between fat depot and 
hormone profiles in girls, suggesting that neither VAT nor SAT are 
independent determinants of sex steroids in healthy girls without 
precocious puberty.
Although adolescence represents a time of relatively rapid accu-
mulations in adipose tissue and changes in sex steroids, few reports 
have examined whether the associations observed in adults are also 
present in healthy children as they accumulate fat and transition 
through puberty.
It has long been recognized that greater body weight and body 
mass index in adult men is inversely related to testosterone concen-
trations, particularly higher fat mass.17 Fewer studies have been able 
to examine whether changes in fat mass over time lead to changes 
in sex steroids, although these reports also suggest that the loss or 
accumulation of fat can influence sex steroids. In one secondary 
analysis of a randomized trial of weight loss, we found that reduc-
tions in VAT and SAT resulted in increases in testosterone among 
overweight adult men.18 In two other observational cohorts, men 
with the greatest weight gains had the greatest declines in testos-
terone over time.19,20 Prepubertal obese boys tend to have higher 
testosterone than nonobese boys21,22 as well as earlier timing of pu-
berty,23 but obese pubertal boys have lower testosterone levels than 
nonobese pubertal boys.24,25
Our findings build upon this literature in several respects. First, 
we note that the rapidity of accumulation of fat is important for 
boys, with more rapid accumulations increasing risk of low testos-
terone in later adolescence. This represents a potentially modifi-
able exposure for children who are obese. Visceral adipose tissue 
growth, as opposed to growth of other tissues, is difficult to assess 
using metrics that are easily accessible to the practicing clinician. 
However, lower energy intake from fat and higher levels of aerobic 
physical activity predict fat deposition in adolescents. 26,27 Thus, 
for the practicing paediatrician, the emphasis on these healthy 
behaviours with the intention of limiting harmful fat accumulation 
can, in turn, influence sex hormone profiles. Preventing rapid gains 
in fat could ameliorate downstream effects on sex hormones. This 
implies that slowing the rate of such fat accumulation will affect 
androgen levels in adolescence, which in turn may impact future 
cardiovascular risk.28
Second, we were able to quantify fat depots precisely through 
the use of MRI as opposed to anthropometric measures, which 
may not represent adiposity in specific compartments. In con-
trast, we did not find associations between fat mass and hormone 
levels in girls. Previous studies have noted that girls have tes-
tosterone levels directly correlated with degree of obesity,2,3,29 
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previous reports for several reasons. We conducted a longitudi-
nal examination of the association between fat and future testos-
terone, and it is possible that fat mass in girls has relatively little 
effect, compared with other factors that are also rapidly chang-
ing during the  pubertal transition.3 These factors include LH and 
fasting insulin, which are related to testosterone levels, even 
after adjustment for adiposity and age.3 In addition, we examined 
the relationship between specific fat depots rather than overall 
body mass, and it is possible that the associations previously ob-
served between body mass and hormone levels reflect other fat 
compartments than VAT and SAT.
Finally, studies have focused upon the relationship between 
obesity and puberty timing, rather than sex steroid levels or 
specific fat measures per se. Puberty is a complex transition of 
which sex hormones are only a single dimension, and thus it is 
possible that a stronger relationship exists between obesity and 
puberty than between VAT, SAT and future sex steroid concen-
trations in girls.
Among boys, the associations between rate of fat mass ac-
cumulation and low testosterone later in adolescence remained 
significant after controlling for several potential mediators or 
confounders of the relationship between fat and testosterone, 
namely insulin,30 leptin,31 LH31 and hepatic fat fraction.32 In con-
trast, the relationships of baseline VAT and baseline SAT with 
future testosterone were no longer significant after adjustment 
for these factors, consistent with prior studies suggesting a po-
tential mediating role of these factors. This suggests that rapid 
accumulations in fat affect sex steroid production through other 
pathways. Although speculative, such pathways could include 
gut hormones such as ghrelin, which may have inhibitory effects 
upon the reproductive axis.33 Other potential pathways include 
other adipokines that may affect sex steroid production through 
direct effects on the gonads or through hypothalamic-pituitary 
pathways.33 Although the majority of circulating androgens in 
boys originate in the testes, small amounts of the adrenal andro-
gen dehydroepiandrosterone are converted to androstenedione 
and then to testosterone. The lack of association between VAT 
and SAT with DHEA suggests that these particular fat depots 
did not have a large impact on adrenal androgen production. 
However, it is possible that adrenal androgen production may 
have influenced deposition of fat and possibly gonadal testoster-
one production.34 Finally, despite the fact that the associations 
between fat mass accumulation and lower testosterone persist 
after controlling for LH, the interpretation of this is complicated 
by the fact that testosterone and LH function in a feedback loop. 
Normal LH concentrations in a male with hypogonadism may 
 actually signify an LH level that is inappropriately low. Therefore, 
the finding that fat accumulation and low testosterone are asso-
ciated while controlling for LH may inappropriately minimize the 
role of obesity in affecting the hypothalamic-pituitary-testicular 
axis and its healthy functioning.
The strengths of this report include a relatively large, diverse 
longitudinal cohort which characterized adiposity using MRI at 2 
points in time along with sex hormone measures and possible medi-
ators. We also used a novel and powerful method of analysis16 that 
allowed us to meaningfully interpret sex hormone levels below the 
level of detection, while avoiding potential bias due to imputation 
or extrapolation of data. However, there are several limitations. We 
examined multiple sex steroids, and we performed multiple com-
parisons. Thus, some of the observed associations may have been 
due to chance and need to be replicated. The optimal method of 
estimating bioavailable testosterone and oestradiol in lieu of direct 
measurements is controversial due to possible changes in binding 
affinity with age and population characteristics. Thus, we did not 
measure free fractions of sex steroids and sex hormone binding 
globulin, and it is possible that use of these measures might yield 
a different pattern of results. We considered this issue carefully 
in constructing the analysis plan, which rests on the probability of 
absence of detectable testosterone. Since total testosterone ex-
ists in equilibrium with free testosterone, the lack of detectable 
total testosterone likely indicates low levels of free testosterone, 
regardless of SHBG levels. If we had examined level of testosterone 
as the outcome with a conventional survival analysis, we agree the 
lack of SHBG would be a significant limitation. We did adjust for he-
patic fat fraction, which is an indicator of fatty liver and correlated 
with sex hormone binding globulin, and adjustment did not alter 
the pattern of results. Body composition may have bidirectional as-
sociations with sex hormones,18 and it is possible that changes in 
sex hormones influenced body fat deposition. To examine whether 
this is the case, we would need to examine whether sex hormone 
changes predicted VAT and SAT at visit 2, after adjustment for 
baseline VAT and SAT, which we plan to examine in the future.
We conclude that the rate of fat accumulation in children may 
influence their hormone profiles in later puberty, and specifically 
that more rapid fat accumulation in boys appears to be associ-
ated with subsequent risk of low testosterone. These associations 
do not seem to occur via insulin levels, hepatic fat, LH or leptin. 
Future studies should explore the potential role of other adi-
pokines or gut peptides upon sex steroid production, and whether 
sex steroid profiles in children alter risk of future adiposity and 
sex hormone disorders in adults. In order to determine whether 
the impact of VAT upon sex steroid profile persists when partici-
pants have completed puberty, another assessment of the cohort 
is planned when participants are approximately 22 years of age. 
Until that assessment, it is not known whether the impact of obe-
sity upon sex steroid profiles is limited to the late-pubertal stage.
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